What We Learned in 2019: Health and Medicine
Developments in medicine and health that we’re still thinking about at year’s end.
Developments in medicine and health that we’re still thinking about at year’s end.
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
The drug, legal in much of the country, is widely seen as nonaddictive and safe. For some users, these assumptions are dangerously wrong.
Some study results tempered enthusiasm for one digital therapeutic but others are showing promising if early results.
Health systems should be collecting diverse data and creating governance structures to account for health equity in their AI use, according to experts.
In Rwanda, 11 deaths have been reported from this rare but deadly disease. Two people tested negative in Germany this week.
As healthcare organizations implement artificial intelligence use cases, they will need the flexibility, scalability and compute power provided by the cloud.
The Texas Attorney General (AG) recently announced a “first-of-its-kind” settlement with a healthcare generative artificial intelligence (AI) company, Pieces Technologies, Inc.
What do updates like the ones Apple introduced actually mean for consumers and fit into an existing healthcare culture? Experts weigh in.
Bessemer Venture Partners released a new report that identifie | Bessemer Venture Partners has released a new road map outlining opportunities for artificial intelligence in…
Public health experts too often fail to sound the alarm.